Copyright Reports & Markets. All rights reserved.

Global Oncology (Anti-cancer Drugs) Market Size, Status and Forecast 2021-2027

Request for Sample of this report
Buy now

1 Report Overview

  • 1.1 Study Scope
  • 1.2 Market Analysis by Type
    • 1.2.1 Global Oncology (Anti-cancer Drugs) Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
    • 1.2.2 Blood Cancer
    • 1.2.3 Breast Cancer
    • 1.2.4 Gastrointestinal Cancer
    • 1.2.5 Prostate Cancer
    • 1.2.6 Others
  • 1.3 Market by Application
    • 1.3.1 Global Oncology (Anti-cancer Drugs) Market Share by Application: 2016 VS 2021 VS 2027
    • 1.3.2 Chemotherapy
    • 1.3.3 Targeted Therapy
    • 1.3.4 Immunotherapy (Biologic Therapy)
    • 1.3.5 Hormonal Therapy
    • 1.3.6 Others
  • 1.4 Study Objectives
  • 1.5 Years Considered

2 Global Growth Trends

  • 2.1 Global Oncology (Anti-cancer Drugs) Market Perspective (2016-2027)
  • 2.2 Oncology (Anti-cancer Drugs) Growth Trends by Regions
    • 2.2.1 Oncology (Anti-cancer Drugs) Market Size by Regions: 2016 VS 2021 VS 2027
    • 2.2.2 Oncology (Anti-cancer Drugs) Historic Market Share by Regions (2016-2021)
    • 2.2.3 Oncology (Anti-cancer Drugs) Forecasted Market Size by Regions (2022-2027)
  • 2.3 Oncology (Anti-cancer Drugs) Industry Dynamic
    • 2.3.1 Oncology (Anti-cancer Drugs) Market Trends
    • 2.3.2 Oncology (Anti-cancer Drugs) Market Drivers
    • 2.3.3 Oncology (Anti-cancer Drugs) Market Challenges
    • 2.3.4 Oncology (Anti-cancer Drugs) Market Restraints

3 Competition Landscape by Key Players

  • 3.1 Global Top Oncology (Anti-cancer Drugs) Players by Revenue
    • 3.1.1 Global Top Oncology (Anti-cancer Drugs) Players by Revenue (2016-2021)
    • 3.1.2 Global Oncology (Anti-cancer Drugs) Revenue Market Share by Players (2016-2021)
  • 3.2 Global Oncology (Anti-cancer Drugs) Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 3.3 Players Covered: Ranking by Oncology (Anti-cancer Drugs) Revenue
  • 3.4 Global Oncology (Anti-cancer Drugs) Market Concentration Ratio
    • 3.4.1 Global Oncology (Anti-cancer Drugs) Market Concentration Ratio (CR5 and HHI)
    • 3.4.2 Global Top 10 and Top 5 Companies by Oncology (Anti-cancer Drugs) Revenue in 2020
  • 3.5 Oncology (Anti-cancer Drugs) Key Players Head office and Area Served
  • 3.6 Key Players Oncology (Anti-cancer Drugs) Product Solution and Service
  • 3.7 Date of Enter into Oncology (Anti-cancer Drugs) Market
  • 3.8 Mergers & Acquisitions, Expansion Plans

4 Oncology (Anti-cancer Drugs) Breakdown Data by Type

  • 4.1 Global Oncology (Anti-cancer Drugs) Historic Market Size by Type (2016-2021)
  • 4.2 Global Oncology (Anti-cancer Drugs) Forecasted Market Size by Type (2022-2027)

5 Oncology (Anti-cancer Drugs) Breakdown Data by Application

  • 5.1 Global Oncology (Anti-cancer Drugs) Historic Market Size by Application (2016-2021)
  • 5.2 Global Oncology (Anti-cancer Drugs) Forecasted Market Size by Application (2022-2027)

6 North America

  • 6.1 North America Oncology (Anti-cancer Drugs) Market Size (2016-2027)
  • 6.2 North America Oncology (Anti-cancer Drugs) Market Size by Type
    • 6.2.1 North America Oncology (Anti-cancer Drugs) Market Size by Type (2016-2021)
    • 6.2.2 North America Oncology (Anti-cancer Drugs) Market Size by Type (2022-2027)
    • 6.2.3 North America Oncology (Anti-cancer Drugs) Market Size by Type (2016-2027)
  • 6.3 North America Oncology (Anti-cancer Drugs) Market Size by Application
    • 6.3.1 North America Oncology (Anti-cancer Drugs) Market Size by Application (2016-2021)
    • 6.3.2 North America Oncology (Anti-cancer Drugs) Market Size by Application (2022-2027)
    • 6.3.3 North America Oncology (Anti-cancer Drugs) Market Size by Application (2016-2027)
  • 6.4 North America Oncology (Anti-cancer Drugs) Market Size by Country
    • 6.4.1 North America Oncology (Anti-cancer Drugs) Market Size by Country (2016-2021)
    • 6.4.2 North America Oncology (Anti-cancer Drugs) Market Size by Country (2022-2027)
    • 6.4.3 United States
    • 6.4.3 Canada

7 Europe

  • 7.1 Europe Oncology (Anti-cancer Drugs) Market Size (2016-2027)
  • 7.2 Europe Oncology (Anti-cancer Drugs) Market Size by Type
    • 7.2.1 Europe Oncology (Anti-cancer Drugs) Market Size by Type (2016-2021)
    • 7.2.2 Europe Oncology (Anti-cancer Drugs) Market Size by Type (2022-2027)
    • 7.2.3 Europe Oncology (Anti-cancer Drugs) Market Size by Type (2016-2027)
  • 7.3 Europe Oncology (Anti-cancer Drugs) Market Size by Application
    • 7.3.1 Europe Oncology (Anti-cancer Drugs) Market Size by Application (2016-2021)
    • 7.3.2 Europe Oncology (Anti-cancer Drugs) Market Size by Application (2022-2027)
    • 7.3.3 Europe Oncology (Anti-cancer Drugs) Market Size by Application (2016-2027)
  • 7.4 Europe Oncology (Anti-cancer Drugs) Market Size by Country
    • 7.4.1 Europe Oncology (Anti-cancer Drugs) Market Size by Country (2016-2021)
    • 7.4.2 Europe Oncology (Anti-cancer Drugs) Market Size by Country (2022-2027)
    • 7.4.3 Germany
    • 7.4.4 France
    • 7.4.5 U.K.
    • 7.4.6 Italy
    • 7.4.7 Russia
    • 7.4.8 Nordic

8 Asia-Pacific

  • 8.1 Asia-Pacific Oncology (Anti-cancer Drugs) Market Size (2016-2027)
  • 8.2 Asia-Pacific Oncology (Anti-cancer Drugs) Market Size by Type
    • 8.2.1 Asia-Pacific Oncology (Anti-cancer Drugs) Market Size by Type (2016-2021)
    • 8.2.2 Asia-Pacific Oncology (Anti-cancer Drugs) Market Size by Type (2022-2027)
    • 8.2.3 Asia-Pacific Oncology (Anti-cancer Drugs) Market Size by Type (2016-2027)
  • 8.3 Asia-Pacific Oncology (Anti-cancer Drugs) Market Size by Application
    • 8.3.1 Asia-Pacific Oncology (Anti-cancer Drugs) Market Size by Application (2016-2021)
    • 8.3.2 Asia-Pacific Oncology (Anti-cancer Drugs) Market Size by Application (2022-2027)
    • 8.3.3 Asia-Pacific Oncology (Anti-cancer Drugs) Market Size by Application (2016-2027)
  • 8.4 Asia-Pacific Oncology (Anti-cancer Drugs) Market Size by Region
    • 8.4.1 Asia-Pacific Oncology (Anti-cancer Drugs) Market Size by Region (2016-2021)
    • 8.4.2 Asia-Pacific Oncology (Anti-cancer Drugs) Market Size by Region (2022-2027)
    • 8.4.3 China
    • 8.4.4 Japan
    • 8.4.5 South Korea
    • 8.4.6 Southeast Asia
    • 8.4.7 India
    • 8.4.8 Australia

9 Latin America

  • 9.1 Latin America Oncology (Anti-cancer Drugs) Market Size (2016-2027)
  • 9.2 Latin America Oncology (Anti-cancer Drugs) Market Size by Type
    • 9.2.1 Latin America Oncology (Anti-cancer Drugs) Market Size by Type (2016-2021)
    • 9.2.2 Latin America Oncology (Anti-cancer Drugs) Market Size by Type (2022-2027)
    • 9.2.3 Latin America Oncology (Anti-cancer Drugs) Market Size by Type (2016-2027)
  • 9.3 Latin America Oncology (Anti-cancer Drugs) Market Size by Application
    • 9.3.1 Latin America Oncology (Anti-cancer Drugs) Market Size by Application (2016-2021)
    • 9.3.2 Latin America Oncology (Anti-cancer Drugs) Market Size by Application (2022-2027)
    • 9.3.3 Latin America Oncology (Anti-cancer Drugs) Market Size by Application (2016-2027)
  • 9.4 Latin America Oncology (Anti-cancer Drugs) Market Size by Country
    • 9.4.1 Latin America Oncology (Anti-cancer Drugs) Market Size by Country (2016-2021)
    • 9.4.2 Latin America Oncology (Anti-cancer Drugs) Market Size by Country (2022-2027)
    • 9.4.3 Mexico
    • 9.4.4 Brazil

10 Middle East & Africa

  • 10.1 Middle East & Africa Oncology (Anti-cancer Drugs) Market Size (2016-2027)
  • 10.2 Middle East & Africa Oncology (Anti-cancer Drugs) Market Size by Type
    • 10.2.1 Middle East & Africa Oncology (Anti-cancer Drugs) Market Size by Type (2016-2021)
    • 10.2.2 Middle East & Africa Oncology (Anti-cancer Drugs) Market Size by Type (2022-2027)
    • 10.2.3 Middle East & Africa Oncology (Anti-cancer Drugs) Market Size by Type (2016-2027)
  • 10.3 Middle East & Africa Oncology (Anti-cancer Drugs) Market Size by Application
    • 10.3.1 Middle East & Africa Oncology (Anti-cancer Drugs) Market Size by Application (2016-2021)
    • 10.3.2 Middle East & Africa Oncology (Anti-cancer Drugs) Market Size by Application (2022-2027)
    • 10.3.3 Middle East & Africa Oncology (Anti-cancer Drugs) Market Size by Application (2016-2027)
  • 10.4 Middle East & Africa Oncology (Anti-cancer Drugs) Market Size by Country
    • 10.4.1 Middle East & Africa Oncology (Anti-cancer Drugs) Market Size by Country (2016-2021)
    • 10.4.2 Middle East & Africa Oncology (Anti-cancer Drugs) Market Size by Country (2022-2027)
    • 10.4.3 Turkey
    • 10.4.4 Saudi Arabia
    • 10.4.5 UAE

11 Key Players Profiles

  • 11.1 Roche
    • 11.1.1 Roche Company Details
    • 11.1.2 Roche Business Overview
    • 11.1.3 Roche Oncology (Anti-cancer Drugs) Introduction
    • 11.1.4 Roche Revenue in Oncology (Anti-cancer Drugs) Business (2016-2021)
    • 11.1.5 Roche Recent Development
  • 11.2 Novartis
    • 11.2.1 Novartis Company Details
    • 11.2.2 Novartis Business Overview
    • 11.2.3 Novartis Oncology (Anti-cancer Drugs) Introduction
    • 11.2.4 Novartis Revenue in Oncology (Anti-cancer Drugs) Business (2016-2021)
    • 11.2.5 Novartis Recent Development
  • 11.3 Celgene
    • 11.3.1 Celgene Company Details
    • 11.3.2 Celgene Business Overview
    • 11.3.3 Celgene Oncology (Anti-cancer Drugs) Introduction
    • 11.3.4 Celgene Revenue in Oncology (Anti-cancer Drugs) Business (2016-2021)
    • 11.3.5 Celgene Recent Development
  • 11.4 Amgen
    • 11.4.1 Amgen Company Details
    • 11.4.2 Amgen Business Overview
    • 11.4.3 Amgen Oncology (Anti-cancer Drugs) Introduction
    • 11.4.4 Amgen Revenue in Oncology (Anti-cancer Drugs) Business (2016-2021)
    • 11.4.5 Amgen Recent Development
  • 11.5 Johnson & Johnson
    • 11.5.1 Johnson & Johnson Company Details
    • 11.5.2 Johnson & Johnson Business Overview
    • 11.5.3 Johnson & Johnson Oncology (Anti-cancer Drugs) Introduction
    • 11.5.4 Johnson & Johnson Revenue in Oncology (Anti-cancer Drugs) Business (2016-2021)
    • 11.5.5 Johnson & Johnson Recent Development
  • 11.6 GlaxoSmithKline
    • 11.6.1 GlaxoSmithKline Company Details
    • 11.6.2 GlaxoSmithKline Business Overview
    • 11.6.3 GlaxoSmithKline Oncology (Anti-cancer Drugs) Introduction
    • 11.6.4 GlaxoSmithKline Revenue in Oncology (Anti-cancer Drugs) Business (2016-2021)
    • 11.6.5 GlaxoSmithKline Recent Development
  • 11.7 Eli lilly & Co
    • 11.7.1 Eli lilly & Co Company Details
    • 11.7.2 Eli lilly & Co Business Overview
    • 11.7.3 Eli lilly & Co Oncology (Anti-cancer Drugs) Introduction
    • 11.7.4 Eli lilly & Co Revenue in Oncology (Anti-cancer Drugs) Business (2016-2021)
    • 11.7.5 Eli lilly & Co Recent Development
  • 11.8 Pfizer
    • 11.8.1 Pfizer Company Details
    • 11.8.2 Pfizer Business Overview
    • 11.8.3 Pfizer Oncology (Anti-cancer Drugs) Introduction
    • 11.8.4 Pfizer Revenue in Oncology (Anti-cancer Drugs) Business (2016-2021)
    • 11.8.5 Pfizer Recent Development
  • 11.9 Merck & Co.
    • 11.9.1 Merck & Co. Company Details
    • 11.9.2 Merck & Co. Business Overview
    • 11.9.3 Merck & Co. Oncology (Anti-cancer Drugs) Introduction
    • 11.9.4 Merck & Co. Revenue in Oncology (Anti-cancer Drugs) Business (2016-2021)
    • 11.9.5 Merck & Co. Recent Development
  • 11.10 Sanofi
    • 11.10.1 Sanofi Company Details
    • 11.10.2 Sanofi Business Overview
    • 11.10.3 Sanofi Oncology (Anti-cancer Drugs) Introduction
    • 11.10.4 Sanofi Revenue in Oncology (Anti-cancer Drugs) Business (2016-2021)
    • 11.10.5 Sanofi Recent Development

12 Analyst's Viewpoints/Conclusions

    13 Appendix

    • 13.1 Research Methodology
      • 13.1.1 Methodology/Research Approach
      • 13.1.2 Data Source
    • 13.2 Disclaimer

    Oncology (Anti-cancer Drugs) market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Oncology (Anti-cancer Drugs) market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

    Segment by Type
    Blood Cancer
    Breast Cancer
    Gastrointestinal Cancer
    Prostate Cancer
    Others

    Segment by Application
    Chemotherapy
    Targeted Therapy
    Immunotherapy (Biologic Therapy)
    Hormonal Therapy
    Others

    By Region
    North America
    U.S.
    Canada
    Europe
    Germany
    France
    U.K.
    Italy
    Russia
    Nordic
    Rest of Europe
    Asia-Pacific
    China
    Japan
    South Korea
    Southeast Asia
    India
    Australia
    Rest of Asia
    Latin America
    Mexico
    Brazil
    Rest of Latin America
    Middle East & Africa
    Turkey
    Saudi Arabia
    UAE
    Rest of MEA

    By Company
    Roche
    Novartis
    Celgene
    Amgen
    Johnson & Johnson
    GlaxoSmithKline
    Eli lilly & Co
    Pfizer
    Merck & Co.
    Amgen

    Buy now